Navigation Links
Sticky surfaces turn slippery with the flip of a molecular light switch

ve to proteins that might stick to its surface, according to Belfort. Exposing the material to UV light is like flipping a molecular switch, causing sticky proteins to detach from the surface and wash away in the liquid, the researchers report.

Not only is the switching mechanism uncomplicated, but so is the patented procedure required to graft spiropyran molecules to poly(ether sulfone). "We used a relatively simple two-step process that could be easily incorporated into a commercial manufacturing process," Belfort says. "The relative ease of this grafting and switching process suggests many industrial opportunities."

In addition to bioseparations, Belfort envisions a number of potential applications for the materials, ranging from new membranes for treating polluted water to the targeted release of drugs in the body.

For example, in recent years researchers have developed "lab-on-a-chip" technology for automating laboratory processes on extremely small scales. Belfort notes that the new material could be employed as a surface valve that can be opened and closed by applying light, offering the ability to control liquid flow in a chip's ultra-tiny channels.

And in sensors designed to detect biological agents, the ability to control the polarity of the membrane could help reduce the attachment of unwanted proteins, providing more accurate readings, according to Belfort.


'"/>

Source:Rensselaer Polytechnic Institute


Page: 1 2

Related biology news :

1. Sticky mice lead to discovery of new cause of neurodegenerative disease
2. Shampoo detergent added to paint makes surfaces self-sterilizing
3. Bacteria can survive for weeks on hospital surfaces
4. Researchers to develop active nanoscale surfaces for biological separations
5. Interfering RNA silences genes in slippery immune cells
6. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
7. Source of molecular triggers in cutaneous T cell lymphoma identified
8. Plants, animals share molecular growth mechanisms
9. NYU researchers simulate molecular biological clock
10. Scientists reveal molecular secrets of the malaria parasite
11. Scientists identify molecular events that drive cell senescence
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sticky surfaces turn slippery with the flip molecular light switch

(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... to their offering. One major trend ... continuous advances in technology, it is important to upgrade ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... crops such as miscanthus, whose high yields have led ... in producing ethanol, are now shown to have another ... in the environment. In a 4-year University of Illinois ... to typical corn-corn-soybean rotations, each of the perennial crops ...
... work on a way to "engineer" a microbe to break ... more fuel. The project, which received a $2.4 million ... the challenge of biowaste generated in biofuel production, according to ... and lead researcher on the project. "Probably one of ...
... difficult problems in the field of genomics is assembling ... a new paper published in Proceedings of the ... genome and computer scientists has solved this problem, creating ... no prior information about how the genome is organized. ...
Cached Biology News:Lower nitrogen losses with perennial biofuel crops 2Lower nitrogen losses with perennial biofuel crops 3AgriLife Research gets grant to crack biofuel production waste issue 2Solving puzzles without a picture 2
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... 2014  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical ... that the Company closed its previously announced private ... Jack W. Schuler , Birchview Fund LLC and ... before offering expenses.  The proceeds will be used ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... 2014 Earlier this year in a June ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... property of adult tissue stem cells. His title “Asymmetric ... for the Future,” embodied the essence of his message to ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Former Pfizer executives to lead regulatory affairs group based in Ann ... ... 25 United BioSource Corporation,(UBC) today announced the expansion of its ... Lang, Dr PH. Based,in Ann Arbor, Michigan, the group will provide ...
... CRT-D and upgraded ... System, NATICK, Mass., Feb. 25 Boston Scientific,Corporation (NYSE: ... three products in its Cardiac Rhythm Management,business. They are:, ... helps protect patients at risk of sudden cardiac ...
... 25 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... first Phase 3 clinical trial with AZ-004 ... being developed for the treatment of,acute agitation ... Alexza,believes the novel, non-invasive nature and rapid ...
Cached Biology Technology:United BioSource Expands Regulatory Affairs Capabilities 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 3Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5
... of DETACHaBEAD Mouse CD4, polyclonal Sheep anti-Mouse ... from Dynabeads Mouse CD4 (L3T4). Detach ... Dynabeads Mouse CD4 using DETACHaBEAD Mouse CD4. ... downstream application including flow cytometry, functional studies ...
Porcine IFN-gamma ELISpot Development Module...
...
Request Info...
Biology Products: